Financhill
Buy
80

EXPE Quote, Financials, Valuation and Earnings

Last price:
$164.75
Seasonality move :
7.43%
Day range:
$163.80 - $166.93
52-week range:
$107.25 - $207.73
Dividend yield:
0.24%
P/E ratio:
18.30x
P/S ratio:
1.65x
P/B ratio:
13.71x
Volume:
1.8M
Avg. volume:
2.4M
1-year change:
41.98%
Market cap:
$21.3B
Revenue:
$13.7B
EPS (TTM):
$9.05

Earnings Data

Next earnings date for EXPE
May 08
2025
Most recent earnings per share
$2.20
Beat by $0.10
(Feb 6/2025)
Consensus Estimate
$2.10
(Feb 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

EXPE Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2025 Q2 $3.7B -- -- $3.93 --
05/08/2025 Q1 $3B -- -- $0.36 --
02/06/2025 Q4 $3.1B $3.2B $2.20 $2.10 $0.10
11/07/2024 Q3 $4.1B $4.1B $5.04 $6.12 -$1.08
08/08/2024 Q2 $3.5B $3.6B $2.80 $3.16 -$0.36
05/02/2024 Q1 $2.8B $2.9B -$0.99 -$0.17 -$0.82
02/08/2024 Q4 $2.9B $2.9B $0.92 $1.70 -$0.78
11/02/2023 Q3 $3.9B $3.9B $2.87 $5.00 -$2.13
08/03/2023 Q2 $3.4B $3.4B $2.54 $2.36 $0.18
05/04/2023 Q1 $2.7B $2.7B -$0.95 $0.03 -$0.98
02/09/2023 Q4 -- $2.6B $1.11 -- --
11/03/2022 Q3 -- $3.6B $2.98 -- --
08/04/2022 Q2 -- $3.2B -$1.17 -- --
05/02/2022 Q1 -- $2.2B -$0.78 -- --
02/10/2022 Q4 -- $2.3B $1.70 -- --
11/04/2021 Q3 -- $3B $2.26 -- --
08/05/2021 Q2 -- $2.1B -$2.02 -- --
05/06/2021 Q1 -- $1.2B -$4.17 -- --
02/11/2021 Q4 -- $920M -$2.89 -- --
11/04/2020 Q3 -- $1.5B -$1.56 -- --
07/30/2020 Q2 -- $566M -$5.34 -- --
05/20/2020 Q1 -- $2.2B -$9.24 -- --
02/13/2020 Q4 -- $2.7B $0.52 -- --
11/06/2019 Q3 -- $3.6B $2.71 -- --
07/25/2019 Q2 -- $3.2B $1.21 -- --
05/02/2019 Q1 -- $2.6B -$0.69 -- --
02/07/2019 Q4 -- $2.6B $0.11 -- --
10/25/2018 Q3 -- $3.3B $3.43 -- --
07/26/2018 Q2 -- $2.9B $0.01 -- --
04/26/2018 Q1 -- $2.5B -$0.91 -- --
02/08/2018 Q4 -- $2.3B $0.35 -- --
10/26/2017 Q3 -- $3B $2.23 -- --
07/27/2017 Q2 -- $2.6B $0.36 -- --
04/27/2017 Q1 -- $2.2B -$0.57 -- --
02/09/2017 Q4 -- $2.1B $0.51 -- --
10/27/2016 Q3 -- $2.6B $1.81 -- --
07/28/2016 Q2 -- $2.2B $0.21 -- --
04/28/2016 Q1 -- $1.9B -$0.72 -- --
02/10/2016 Q4 -- $1.7B -$0.09 -- --
10/29/2015 Q3 -- $1.9B $2.12 -- --
07/30/2015 Q2 -- $1.7B $3.38 -- --

Expedia Group Earnings Questions

  • How Much did Expedia Group Generate in Revenue Last Quarter?

    Expedia Group reported $3.2B worth of top line sales in its most recent quarter.

  • Did Expedia Group Beat Earnings Last Quarter?

    Expedia Group announced earnings per share of $2.20 which represents a beat of analyst forecast a $2.10 per share.

  • Is Expedia Group Profitable?

    Expedia Group reported $2.8B that represents $20.99 per share over the last quarter.

  • What is the Analyst Consensus for Expedia Group EPS Next Year?

    Expedia Group's earnings are forecast to grow from $8.95 per share to $11.92 per share next year representing an increase of 60.11%.

  • When is Expedia Group's Earnings Date?

    Expedia Group's next earnings date is May 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Broadcom Stock a Millionaire Maker?
Is Broadcom Stock a Millionaire Maker?

Broadcom (Nasdaq: AVGO) stock has gone up more than 64%…

Is Berkshire The Best Stock to Buy in a Bad Market?
Is Berkshire The Best Stock to Buy in a Bad Market?

Berkshire Hathaway (NYSE:BRK.A, BRK.B) has historically been one of the…

Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?
Is Shopify Stock Still a Buy in 2025 or Has Growth Peaked?

The big picture trends in e‑commerce sales are clearly in…

Stock Ideas

Buy
71
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Buy
63
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
60
RGC alert for May 6

Regencell Bioscience Holdings [RGC] is up 73.72% over the past day.

Buy
63
SKX alert for May 6

Skechers USA [SKX] is down 0.07% over the past day.

Sell
20
PTCT alert for May 6

PTC Therapeutics [PTCT] is down 11% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock